Drug patent settlements may be illegal, DOJ says

The U.S. Justice Department said settlements in which makers of brand-name drugs pay to delay the introduction of generic competitors should be considered illegal in many cases. The department, in a filing Monday with the 2nd U.S. Circuit Court of Appeals in New York in a case involving Bayer AG and the anthrax treatment Cipro, said ...

Enter your user name and password in the fields above to gain access to the subscriber content on this site. Need a subscription? Click here.
Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time.
If you feel your login credentials are being used by a second party, contact customer service at 877-615-9536 for assistance in changing your password.

Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.

Forgot your password?

MLM Counties News. Notices. Need-to-know Information.

Drug patent settlements may be illegal, DOJ says

Leave a Reply